BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim GH, Min YW, Lee H, Min BH, Lee JH, Rhee PL, Kim JJ. Risk factors of metachronous recurrence after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. PLoS One 2020;15:e0238113. [PMID: 32886924 DOI: 10.1371/journal.pone.0238113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Pimentel-Nunes P, Libânio D, Bastiaansen BAJ, Bhandari P, Bisschops R, Bourke MJ, Esposito G, Lemmers A, Maselli R, Messmann H, Pech O, Pioche M, Vieth M, Weusten BLAM, van Hooft JE, Deprez PH, Dinis-Ribeiro M. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022. Endoscopy 2022. [PMID: 35523224 DOI: 10.1055/a-1811-7025] [Reference Citation Analysis]
2 Cui Y, Zhang S, Hu X, Gao F. Tumor-associated fibroblasts derived exosomes induce the proliferation and cisplatin resistance in esophageal squamous cell carcinoma cells through RIG-I/IFN-β signaling. Bioengineered 2022;13:12462-74. [PMID: 35587143 DOI: 10.1080/21655979.2022.2076008] [Reference Citation Analysis]
3 Ekeke CN, Chan EG, Fabian T, Villa-Sanchez M, Luketich JD. Recommendations for Surveillance and Management of Recurrent Esophageal Cancer Following Endoscopic Therapies. Surg Clin North Am 2021;101:415-26. [PMID: 34048762 DOI: 10.1016/j.suc.2021.03.004] [Reference Citation Analysis]